(SPG) SP - Ratings and Ratios
Plastic Parts, Foam Products, Coated Surfaces, Medical Devices, Marine Buoys
SPG EPS (Earnings per Share)
SPG Revenue
Description: SPG SP
SP Group A/S is a global manufacturer and supplier of moulded plastic and composite components, serving various industries including healthcare, cleantech, and foodtech. The companys diverse product portfolio includes hydrographic printing, electromagnetic shielding, and other coatings, as well as ventilation equipment, ergonomic mats, and striping products.
With a presence in multiple regions, including Europe, the Americas, Asia, and Africa, SP Group A/S has established itself as a significant player in the specialty chemicals industry. Its products cater to a range of applications, from refrigerators and cars to medical devices and maritime equipment. The companys capabilities extend to 3D printing, CNC plastics machining, and plastic parts manufacturing, as well as coatings on plastic and metal components.
From a financial perspective, SP Group A/S has a market capitalization of 3846.23M DKK, indicating a substantial presence in the market. Its price-to-earnings ratio stands at 12.90, suggesting a relatively attractive valuation. The companys return on equity (RoE) is 16.48%, indicating a decent level of profitability. To further evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, EBITDA margin, and debt-to-equity ratio can be examined. For instance, a high revenue growth rate and EBITDA margin would indicate a strong operational performance, while a low debt-to-equity ratio would suggest a healthy balance sheet.
Some potential KPIs to monitor for SP Group A/S include: - Revenue growth rate: to assess the companys ability to expand its business - EBITDA margin: to evaluate the companys operational profitability - Debt-to-equity ratio: to gauge the companys leverage and financial stability - Return on capital employed (ROCE): to assess the companys ability to generate returns on its capital - Operating cash flow: to evaluate the companys ability to generate cash from its operations
SPG Stock Overview
| Market Cap in USD | 495m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
SPG Stock Ratings
| Growth Rating | -17.9% |
| Fundamental | 63.9% |
| Dividend Rating | 1.0% |
| Return 12m vs S&P 500 | -19.5% |
| Analyst Rating | - |
SPG Dividends
Currently no dividends paidSPG Growth Ratios
| Growth Correlation 3m | -76.4% |
| Growth Correlation 12m | -49.8% |
| Growth Correlation 5y | -32% |
| CAGR 5y | 4.17% |
| CAGR/Max DD 5y | 0.07 |
| Sharpe Ratio 12m | -0.11 |
| Alpha | -18.27 |
| Beta | 0.960 |
| Volatility | 39.78% |
| Current Volume | 16.2k |
| Average Volume 20d | 16.1k |
| Stop Loss | 262.8 (-3.6%) |
| Signal | 0.27 |
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (273.2m TTM) > 0 and > 6% of Revenue (6% = 179.1m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 3.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.65% (prev 15.72%; Δ 3.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 519.1m > Net Income 273.2m (YES >=105%, WARN >=100%) |
| Net Debt (195.2m) to EBITDA (205.6m) ratio: 0.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (12.0m) change vs 12m ago -0.85% (target <= -2.0% for YES) |
| Gross Margin 69.93% (prev 26.28%; Δ 43.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.87% (prev 85.18%; Δ 9.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.51 (EBITDA TTM 205.6m / Interest Expense TTM 12.2m) >= 6 (WARN >= 3) |
Altman Z'' 4.34
| (A) 0.18 = (Total Current Assets 1.33b - Total Current Liabilities 743.4m) / Total Assets 3.22b |
| (B) 0.52 = Retained Earnings (Balance) 1.68b / Total Assets 3.22b |
| (C) 0.03 = EBIT TTM 103.9m / Avg Total Assets 3.15b |
| (D) 1.16 = Book Value of Equity 1.68b / Total Liabilities 1.45b |
| Total Rating: 4.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.89
| 1. Piotroski 8.50pt = 3.50 |
| 2. FCF Yield 7.61% = 3.81 |
| 3. FCF Margin 10.36% = 2.59 |
| 4. Debt/Equity 0.58 = 2.34 |
| 5. Debt/Ebitda 4.95 = -2.50 |
| 6. ROIC - WACC -2.11% = -2.63 |
| 7. RoE 16.48% = 1.37 |
| 8. Rev. Trend 65.64% = 3.28 |
| 9. Rev. CAGR 5.41% = 0.68 |
| 10. EPS Trend 28.33% = 0.71 |
| 11. EPS CAGR 7.54% = 0.75 |
What is the price of SPG shares?
Over the past week, the price has changed by +0.55%, over one month by -0.91%, over three months by -11.09% and over the past year by -5.87%.
Is SP a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPG is around 242.69 DKK . This means that SPG is currently overvalued and has a potential downside of -10.94%.
Is SPG a buy, sell or hold?
What are the forecasts/targets for the SPG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 380 | 39.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 268.1 | -1.6% |
SPG Fundamental Data Overview
Market Cap DKK = 3.16b (3.16b DKK * 1.0 DKK.DKK)
CCE Cash And Equivalents = 115.6m DKK (Cash only, last quarter)
P/E Trailing = 11.7205
P/S = 1.0893
P/B = 1.8275
Beta = 0.932
Revenue TTM = 2.99b DKK
EBIT TTM = 103.9m DKK
EBITDA TTM = 205.6m DKK
Long Term Debt = 706.0m DKK (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 310.8m DKK (from shortLongTermDebt, last quarter)
Debt = 1.02b DKK (Calculated: Short Term 310.8m + Long Term 706.0m)
Net Debt = 195.2m DKK (from netDebt column, last quarter)
Enterprise Value = 4.06b DKK (3.16b + Debt 1.02b - CCE 115.6m)
Interest Coverage Ratio = 8.51 (Ebit TTM 103.9m / Interest Expense TTM 12.2m)
FCF Yield = 7.61% (FCF TTM 309.3m / Enterprise Value 4.06b)
FCF Margin = 10.36% (FCF TTM 309.3m / Revenue TTM 2.99b)
Net Margin = 9.15% (Net Income TTM 273.2m / Revenue TTM 2.99b)
Gross Margin = 69.93% ((Revenue TTM 2.99b - Cost of Revenue TTM 897.5m) / Revenue TTM)
Tobins Q-Ratio = 2.42 (Enterprise Value 4.06b / Book Value Of Equity 1.68b)
Interest Expense / Debt = 1.20% (Interest Expense 12.2m / Debt 1.02b)
Taxrate = 23.88% (from yearly Tax Provision: 82.3m / 344.8m)
NOPAT = 79.1m (EBIT 103.9m * (1 - 23.88%))
Current Ratio = 1.79 (Total Current Assets 1.33b / Total Current Liabilities 743.4m)
Debt / Equity = 0.58 (Debt 1.02b / last Quarter total Stockholder Equity 1.76b)
Debt / EBITDA = 4.95 (Net Debt 195.2m / EBITDA 205.6m)
Debt / FCF = 3.29 (Debt 1.02b / FCF TTM 309.3m)
Total Stockholder Equity = 1.66b (last 4 quarters mean)
RoA = 8.50% (Net Income 273.2m, Total Assets 3.22b )
RoE = 16.48% (Net Income TTM 273.2m / Total Stockholder Equity 1.66b)
RoCE = 4.39% (Ebit 103.9m / (Equity 1.66b + L.T.Debt 706.0m))
RoIC = 5.34% (NOPAT 79.1m / Invested Capital 1.48b)
WACC = 7.45% (E(3.16b)/V(4.18b) * Re(9.55%)) + (D(1.02b)/V(4.18b) * Rd(1.20%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -0.39%
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.70% ; FCFE base≈258.6m ; Y1≈319.0m ; Y5≈544.3m
Fair Price DCF = 592.5 (DCF Value 7.07b / Shares Outstanding 11.9m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 65.64 | Revenue CAGR: 5.41%
Rev Growth-of-Growth: 10.39
EPS Correlation: 28.33 | EPS CAGR: 7.54%
EPS Growth-of-Growth: 74.86